Ligand id: 6778

Name: ofatumumab

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: ofatumumab

Compound class Antibody
Approved drug? Yes (FDA (2009), EMA (2010))
International Nonproprietary Names
INN number INN
8606 ofatumumab
Arzerra® | GSK 1841157 | GSK1841157 | humax-CD20
Database Links
Specialist databases
IMGT/mAb-DB 194
Other databases
GtoPdb PubChem SID 178103384
PubChem SID 178103384
Search PubMed clinical trials ofatumumab
Search PubMed titles ofatumumab
Search PubMed titles/abstracts ofatumumab
Wikipedia Ofatumumab
Ofatumumab is a type I anti-CD20 monoclonal, designed to target surface CD20 on B-lymphocytes.